1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. TCR2 Therapeutics Inc (TCRR)
  7. Quote

TCRR TCRR

TCR2 Therapeutics Stock Price

5.19
0.17 (3.39%)
Upgrade to Real-Time
Regular Market
5.19
Volume 245,896
Bid Price 5.18
Ask Price 5.20
News -
Day High 5.22

Low
4.96

52 Week Range

High
35.86

Day Low 4.96
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
TCR2 Therapeutics Inc TCRR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.17 3.39% 5.19 12:09:20
Open Price Low Price High Price Close Price Prev Close
5.00 4.96 5.22 5.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,874 245,896 $ 5.14 $ 1,263,693 - 4.96 - 35.86
Last Trade Time Type Quantity Stock Price Currency
12:09:25 2 $ 5.18 USD

Period:

Draw Mode:

TCR2 Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 198.36M 38.22M 25.32M $ - $ - -2.42 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 24.97k 0.30%

more financials information »

TCR2 Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TCRR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.475.544.965.141,303,400-0.28-5.12%
1 Month7.007.3294.965.99746,257-1.81-25.86%
3 Months18.0819.034.968.27932,227-12.89-71.29%
6 Months18.9319.654.9610.53614,357-13.74-72.58%
1 Year26.9035.864.9617.39555,872-21.71-80.71%
3 Years15.1435.864.9617.40291,884-9.95-65.72%
5 Years15.1435.864.9617.40291,884-9.95-65.72%

TCR2 Therapeutics Description

TCR2 Therapeutics Inc is a biotechnology company. It is engaged in developing a new generation of T cell therapies for patients suffering from cancer. Its TCR Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing the entire T cell receptor TCR signaling complex, which is effective in patients with solid tumors.


Your Recent History
NASDAQ
TCRR
TCR2 Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.